Today: 27 June 2026
Everspin Heads Into Weekend After Insider Selloff and Tech Losses
16 May 2026
2 mins read

Everspin Heads Into Weekend After Insider Selloff and Tech Losses

New York, May 16, 2026, 16:02 (EDT)

  • Everspin shares lost 7.5% to end Friday at $37.57 and slipped again after the bell to $37.00. But for the week, the stock finished about 39% above its May 8 close.
  • Director Glen Hawk sold 48,563 shares, an SEC filing showed Friday. The stock has seen heavy volume.

Everspin Technologies shares slipped Friday after some choppy trading, but the stock still posted a sharp weekly advance. The small-cap semiconductor name stayed active with memory-chip traders.

Shares fell 7.53% to $37.57 on Friday and slid to $37.00 after the bell. The stock had closed at $26.99 a week ago, so even with losses in the last three sessions, it’s up close to 39% this week.

Everspin shares are in the spotlight with traders weighing the recent set of defense contracts, fresh manufacturing news, and earnings. The company builds MRAM, or magnetoresistive random access memory chips, which hold data without power. That keeps Everspin in the mix with industrial, aerospace, auto and data center buyers concerned with data loss.

Stocks sold off again as the market stayed heavy. The Nasdaq Composite dropped 1.5% Friday. The Russell 2000 slid 2.4%. Tech led the way down from record levels.

Everspin stock surged earlier in the week, jumping 47.7% on Monday and gaining 10.4% Tuesday. Shares gave back ground after that, falling 5.8% Wednesday, down another 2.0% Thursday, and losing 7.5% Friday. The stock reached a 52-week high of $51.50 on Wednesday before retreating.

Everspin shares moved higher after the company posted first-quarter results and announced a defense contract. Revenue climbed to $14.87 million, up from $13.14 million. Product sales totaled $14.1 million, compared with $11.0 million last year. Net loss narrowed to $296,000, or 1 cent per share. “Strength in Industrial Automation, Transportation, and Data Center applications,” CEO Sanjeev Aggarwal said. SEC

Everspin is forecasting second-quarter revenue of $15.5 million to $16.5 million but says it will remain unprofitable by standard accounting measures. The company said its outlook leaves out any impact from a new subcontract.

Everspin is working as a subcontractor for Amentum Services on a $40 million deal announced late last month. The company said it will support U.S. government needs for onshore Toggle MRAM production. SEC filings show milestone payments in two phases over 30 months, with project completion expected in November 2028.

Aggarwal said in the contract release that the work ties to programs needing “performance, reliability, longevity and U.S. domestic production.” On the earnings call, CFO Bill Cooper said the subcontract should have a “significant positive impact over the next 2.5 years.” No detailed revenue timing yet from the company. Everspin Technologies Inc.

Hawk unloaded shares in four separate blocks, selling between $37.10 and $39.97, according to a new Form 4. The filing showed 39,551 shares still held after the transactions.

Everspin stays out of the main memory market, instead betting on its own technology to grab more of the supply chain. In April, it struck a deal with Microchip Technology to set up some U.S. foundry work at Microchip’s plant in Oregon. In its filings, Everspin also points to a strategic tie with GlobalFoundries for 300mm STT-MRAM, another MRAM variant.

Everspin ended Friday well below its Wednesday peak, with much of the move looking like traders already priced in gains ahead of real revenue. Management says it can take 18 to 24 months for product qualification with customers. If contract revenue lands later than bulls want, or small-cap tech stays weak Monday, shares may slip more.

Everspin Technologies Inc. isn’t scheduled for any investor events this week. Some traders are eyeing fresh SEC filings and shifts in the Nasdaq. There’s also focus on when the $40 million subcontract and Microchip manufacturing expansion will begin hitting revenue.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Sangoma Technologies Stock Fair Value Cut as Analysts Adjust Assumptions
    June 27, 2026, 10:56 AM EDT. Sangoma Technologies (TSX:STC) saw its fair value estimate cut from CA$11.36 to CA$9.92 as analysts revised key assumptions including revenue growth and profit margins. The revenue growth outlook shifted from a 4.33% decline to a 2.24% increase, while net profit margin assumptions were significantly adjusted. The price-to-earnings (P/E) ratio forecast moved higher from 14.51x to 18.10x, and the discount rate for cash flows rose from 7.71% to 8.52%, reflecting increased risk. Analysts remain cautiously optimistic about the company's execution potential but highlight valuation uncertainties. This update underscores the evolving narrative around Sangoma's financial prospects and invites investors to reassess risks and opportunities in the stock.

Latest articles

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

GameStop (NYSE:GME) holds close to cash levels after company guides for $600 million in EBITDA

27 June 2026
GameStop surged 3.57% to $21.76 and jumped after hours as it forecast FY2026 adjusted EBITDA above $600 million, nearly doubling from 2025; with a $9.76 billion market cap now close to its $9.7 billion in cash, securities, digital assets, and collateral, investors are weighing whether GameStop’s cash-rich balance sheet can support equity while Ryan Cohen pursues an eBay bid.
ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

27 June 2026
ImmunityBio surged 11.8% to $8.71 on Friday with volume tripling its average, as Russell index reconstitution took effect; Monday’s trading will reveal if demand persists or if the spike was driven by index flows, with no imminent company events and recent insider selling accounting for just 0.06% of Friday’s volume.
Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

27 June 2026
Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
Court ruling on student loans hits private lenders’ health grad loan push

Court ruling on student loans hits private lenders’ health grad loan push

27 June 2026
Judge blocks narrow “professional degree” rule, letting more health-care grad students keep higher federal loan caps; $7.87B in 2023-24 borrowing above new limits remains in federal market, trimming but not eliminating the $4.5B-$5B annual private loan growth Sallie Mae projected from Grad PLUS loan cuts.
Hyliion Stock Surges Almost 90% This Week; Monday Trading Could Set Next Move
Previous Story

Hyliion Stock Surges Almost 90% This Week; Monday Trading Could Set Next Move

Stripe’s secondary share price brings focus back to its paused IPO
Next Story

Stripe’s secondary share price brings focus back to its paused IPO

Go toTop